Jurado, J.M.; Gutiérrez, V.; Cantero, A.; Berciano-Guerrero, M.-Á.; Padilla, A.; Pérez-Ruiz, E.; Montesa, Á.; Carabantes, F.; Cobo, M.
Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer. J. Clin. Med. 2025, 14, 2499.
https://doi.org/10.3390/jcm14072499
AMA Style
Jurado JM, Gutiérrez V, Cantero A, Berciano-Guerrero M-Á, Padilla A, Pérez-Ruiz E, Montesa Á, Carabantes F, Cobo M.
Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 2025; 14(7):2499.
https://doi.org/10.3390/jcm14072499
Chicago/Turabian Style
Jurado, José Miguel, Vanesa Gutiérrez, Alexandra Cantero, Miguel-Ángel Berciano-Guerrero, Airam Padilla, Elisabet Pérez-Ruiz, Álvaro Montesa, Francisco Carabantes, and Manuel Cobo.
2025. "Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer" Journal of Clinical Medicine 14, no. 7: 2499.
https://doi.org/10.3390/jcm14072499
APA Style
Jurado, J. M., Gutiérrez, V., Cantero, A., Berciano-Guerrero, M.-Á., Padilla, A., Pérez-Ruiz, E., Montesa, Á., Carabantes, F., & Cobo, M.
(2025). Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 14(7), 2499.
https://doi.org/10.3390/jcm14072499
